Avista Healthcare

Acquisition of Novel MRA Contrast Agent for Peripheral Vascular Imaging Expands Company Product Offerings and Supports Future Growth N. Billerica, MA, April 7, 2009 – Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, announced today that it has acquired from EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) the U.S., Canadian, and Australian rights to MS-325 (formerly […]

Houston, TX, October 15, 2008 – (BUSINESS WIRE) — MedServe, with its operating subsidiaries, ENSERV, ENVIROSOLVE, and MedShred, has been recognized as one of Houston Business Journal’s FAST 100 companies for 2008. With a percentage of revenue growth of 910.7% for the period of 2005 through 2007, MedServe was ranked 3rd in this year’s “HOUSTON […]

New York, NY, August 11, 2008 – Avista Capital Partners, a leading private equity firm that invests primarily in growth-oriented healthcare, media, and energy companies, today announced that it has appointed Dr. Patrick J. O’Neill, formerly of Johnson & Johnson, a Healthcare Industry Advisor. Dr. O’Neill had a long and successful career at Johnson & […]

August 4, 2008 – Navilyst Medical, formerly Boston Scientific’s Fluid Management and Vascular Access businesses, today announced its new company name following the February 2008 acquisition by Avista Capital Partners, a private equity firm focused on growth-oriented healthcare, energy and media companies. “Navilyst Medical combines the best attributes of an established medical device company—market-leading technology, […]

Skillman, NJ, August 1, 2008 – Nordic Capital and Avista Capital Partners today announced they have completed the acquisition of ConvaTec from Bristol-Myers Squibb Company. ConvaTec, based in Skillman, NJ, is a world leader in the development and marketing of innovative wound therapeutics, critical care and ostomy care products. David Johnson will remain CEO of […]

June 27, 2008 – Nordic Capital and Avista Capital Partners announce today that following the closing of their acquisition of ConvaTec, a world leader in the development and marketing of innovative wound therapeutics and ostomy care products based in Skillman, New Jersey, which is anticipated to occur in the third quarter, they intend to combine […]

New York, NY, May 2, 2008 – Bristol-Myers Squibb Company (NYSE:BMY) announced today it has signed a definitive agreement to sell its ConvaTec business unit to Nordic Capital Fund VII (“Nordic Capital”) and Avista Capital Partners (“Avista”) for approximately $4.1 billion subject to adjustments based on ConvaTec’s audited 2007 financial statements and closing working capital. […]

N. Billerica, MA, March 18, 2008 – A worldwide leader and pioneer in medical imaging announces new name—Lantheus Medical Imaging—and management team. In business for more than half a century, the company most recently known as Bristol-Myers Squibb Medical Imaging, provides innovative medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures, including Cardiolite® […]

New York, NY, December 17, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Avista Capital Partners, a leading private equity firm, announced today the parties have signed a definitive agreement for Avista to acquire Bristol-Myers Squibb Medical Imaging (“BMS MI”), a business unit of Bristol-Myers Squibb, for approximately $525 million of cash proceeds. BMS MI […]

Natick, MA and New York, NY December 13, 2007 – Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the signing of a definitive agreement under which Avista will acquire from Boston Scientific its Fluid Management and Venous Access businesses for $425 million in cash. The transaction […]

Rockville, MD, December 3, 2007 – (BUSINESS WIRE) — BioReliance Corporation announced today that David A. Dodd has been named President, Chief Executive Officer and Chairman of the Board of the Company, effective today. BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services […]

Acquisition will add to the branded dermatologic line as a growth driver for the future Integration of Bradley will provide an enhanced platform for in-licensing and co-promotion of dermatology products Bradley Pharmaceuticals will be integrated with the PharmaDerm and Fougera divisions of Nycomed’s US specialty business Combined sales of Nycomed US and Bradley amount to […]